645 filings
8-K
LPCN
Lipocine Inc
11 Apr 24
Lipocine Announces Positive LPCN 2401 Clinical Results Showing Improved Body Composition in Participants with Obesity
7:24am
8-K
LPCN
Lipocine Inc
28 Mar 24
Lipocine Announces Positive Week 52 Results from LPCN 1148 Phase 2 Study in Patients with Cirrhosis
6:26am
8-K
LPCN
Lipocine Inc
25 Mar 24
Lipocine Announces First Cohort Dosed in Pivotal Study of LPCN 1154
6:14am
4
LPCN
Lipocine Inc
12 Mar 24
Lipocine / Mahesh V. Patel ownership change
5:53pm
4
LPCN
Lipocine Inc
12 Mar 24
Lipocine / Krista Fogarty ownership change
5:51pm
8-K
LPCN
Lipocine Inc
7 Mar 24
Other Events
5:31pm
8-K
LPCN
Lipocine Inc
7 Mar 24
Results of Operations and Financial Condition
6:08am
10-K
2023 FY
LPCN
Lipocine Inc
Annual report
7 Mar 24
6:07am
8-K
LPCN
Lipocine Inc
6 Mar 24
Lipocine to Present at 36th Annual Roth Conference
6:01am
8-K
LPCN
Lipocine Inc
12 Feb 24
Lipocine Announces Confirmation of Dosing Regimen for Pivotal Study of LPCN 1154
4:10pm
8-K
LPCN
Lipocine Inc
18 Jan 24
Lipocine and Verity Pharma Enter into License Agreement
8:20am
8-K
LPCN
Lipocine Inc
8 Jan 24
Other Events
6:35pm
8-K
LPCN
Lipocine Inc
19 Dec 23
Lipocine to Present at Biotech Showcase 2024
10:00am
S-3
LPCN
Lipocine Inc
Shelf registration
22 Nov 23
4:15pm
8-K
LPCN
Lipocine Inc
13 Nov 23
Lipocine Releases Late Breaking Presentation on LPCN 1148 Phase 2 Results at The Liver MeetingĀ® 2023
2:45pm
10-Q
2023 Q3
LPCN
Lipocine Inc
Quarterly report
8 Nov 23
1:15pm
8-K
LPCN
Lipocine Inc
8 Nov 23
Other Events
9:50am
8-K
LPCN
Lipocine Inc
1 Nov 23
Lipocine to Present Clinical Data on LPCN 1148 at The Liver MeetingĀ® 2023
9:31am
8-K
LPCN
Lipocine Inc
26 Oct 23
Lipocine Completes Successful Meeting with FDA on LPCN 1154 in Postpartum Depression
9:35am
8-K
LPCN
Lipocine Inc
23 Oct 23
Other Events
8:52pm